Target intelligence / Profile preview

RNA, Ro60-associated Y1 pseudogene 9 (RNY1P9)

Target
RNY1P9
Molecular classification
Other (Non-protein coding RNA, Pseudogene, Long non-coding RNA)
01

Overview

RNA, Ro60-associated Y1 pseudogene 9 (RNY1P9) is a non-protein coding transcript classified as a pseudogene related to the RNY1 gene, which encodes Ro-associated Y RNA involved in ribonucleoprotein complexes[5]. Pseudogenes like RNY1P9 typically arise from duplication or retrotransposition events and usually do not produce functional proteins; their main biological effects are often regulatory, such as acting as competitive endogenous RNAs (ceRNAs) or miRNA sponges in post-transcriptional regulation[4]. RNY1P9 is annotated as an intronic noncoding transcript from the KLHL22 gene region but is not itself a receptor, enzyme, or other conventional drug target. There is no published evidence assigning a canonical therapeutic role, direct involvement in disease, or known drug interaction. The available evidence does not suggest any utility as a biomarker or any safety concern. Most current knowledge on pseudogenes is extrapolated from other family members, and primary function or clinical importance is likely null or unknown for RNY1P9 specifically[4][5].

Other names
KLHL22-IT1RNYP1KLHL22 intronic transcript 1 (non-protein coding)RNA, Ro-associated Y, pseudogene 1RNA, Ro-associated Y1 pseudogene 9RNY1P9
02

Biological functions

Other (typical for pseudogenes: possible regulatory effects via ceRNA mechanisms or noncoding RNA-related modulation; no direct protein function)
03

Disease associations

Other (pseudogenes may have indirect roles in disease via RNA-based regulatory mechanisms or miRNA sponge activity; no direct association reported for RNY1P9)

Beyond the preview

Go deeper on RNA, Ro60-associated Y1 pseudogene 9 (RNY1P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, Ro60-associated Y1 pseudogene 9 (RNY1P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call